ArticleJournal of translational medicine2023

SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion.

Zean Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.